Immunoprotein Diagnostic Testing Market by Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-linked Immunosorbent assay and Others), Type (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, and Free Light Chain Diagnostic Test and Others), and Application (Autoimmune Disease Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, and Toxicology Testing): Global Opportunity Analysis and Industry Forecast, 2020–2027

1.1.Report description

1.1.Key benefits for stakeholders

1.2.Key market segments

1.3.Research Methodology

1.3.1.Secondary research

1.3.2.Primary research

1.3.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market Definition and Scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s Five Forces Analysis

3.4.Market Dynamics

3.4.1.Drivers

3.4.1.1.Increasing incidence of chronic and infectious diseases

3.4.1.2.Technological advancements

3.4.2.Restraint

3.4.2.1.Stringent Regulations

3.4.3.Opportunities

3.4.3.1.Lucrative opportunities from emerging economies

3.4.3.2.Development of condition-specific assays and tests

3.5.COVID-19 Impact Analysis on Market

CHAPTER 4:IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast

4.2.Radioimmunoassay (RIA)

4.2.1.Key market trends and opportunities

4.2.2.Market size and forecast

4.2.3.Market analysis, by country

4.3.Immunoturbidity assay

4.3.1.Key market trends and opportunities

4.3.2.Market size and forecast

4.3.3.Market analysis, by country

4.4.Immunoprotein Electrophoresis

4.4.1.Key market trends and opportunities

4.4.2.Market size and forecast

4.4.3.Market analysis, by country

4.5.Enzyme Based Immunoassay

4.5.1.Key market trends and opportunities

4.5.2.Market size and forecast

4.5.3.Market analysis, by country

4.5.3.1.Chemiluminescence Immunoassay (CLIA)

4.5.3.2.Immunofluorescence Assay

4.5.3.3.Colorimetric Immunoassay (CI)

4.6.Others

4.6.1.Key market trends and opportunities

4.6.2.Market size and forecast

4.6.3.Market analysis, by country

CHAPTER 5:IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE

5.1.Overview

5.1.1.Market size and forecast, by type

5.2.C-reactive protein diagnostic tests

5.2.1.Market size and forecast

5.2.2.Market analysis, by country

5.3.Complement system protein diagnostic tests

5.3.1.Market size and forecast

5.3.2.Market analysis, by country

5.4.Pre-albumin diagnostic tests

5.4.1.Market size and forecast

5.4.2.Market analysis, by country

5.5.Haptoglobin diagnostic tests

5.5.1.Market size and forecast

5.5.2.Market analysis, by country

5.6.Immunoglobulin diagnostic tests

5.6.1.Market size and forecast

5.6.2.Market analysis, by country

5.7.Free light chain diagnostic tests

5.7.1.Market size and forecast

5.7.2.Market analysis, by country

5.8.Others

5.8.1.Market size and forecast

5.8.2.Market analysis, by country

CHAPTER 6:IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Autoimmune Testing

6.2.1.Market size and forecast

6.2.2.Market analysis, by country

6.3.Infectious Disease Testing

6.3.1.Market size and forecast

6.3.2.Market analysis, by country

6.4.Allergy Testing

6.4.1.Market size and forecast

6.4.2.Market analysis, by country

6.5.Endocrine Testing

6.5.1.Market size and forecast

6.5.2.Market analysis, by country

6.6.Oncology Testing

6.6.1.Market size and forecast

6.6.2.Market analysis, by country

6.7.Toxicology Testing

6.7.1.Market size and forecast

6.7.2.Market analysis, by country

6.8.Others

6.8.1.Market size and forecast

6.8.2.Market analysis, by country

CHAPTER 7:IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities

7.2.2.Market size and forecast, by country

7.2.3.Market size and forecast, by technology

7.2.4.Market size and forecast, by type

7.2.5.Market size and forecast, by application

7.2.6.U.S.

7.2.6.1.U.S. market size and forecast, by technology

7.2.6.2.U.S. market size and forecast, by type

7.2.6.3.U.S. market size and forecast, by application

7.2.7.Canada

7.2.7.1.Canada market size and forecast, by technology

7.2.7.2.Canada market size and forecast, by type

7.2.7.3.Canada market size and forecast, by application

7.2.8.Mexico

7.2.8.1.Mexico market size and forecast, by technology

7.2.8.2.Mexico market size and forecast, by type

7.2.8.3.Mexico market size and forecast, by application

7.3.Europe

7.3.1.Key market trends and opportunities

7.3.2.Market size and forecast, by country

7.3.3.Market size and forecast, by technology

7.3.4.Market size and forecast, by type

7.3.5.Market size and forecast, by application

7.3.6.Germany

7.3.6.1.Germany market size and forecast, by technology

7.3.6.2.Germany market size and forecast, by type

7.3.6.3.Germany market size and forecast, by application

7.3.7.France

7.3.7.1.France market size and forecast, by technology

7.3.7.2.France market size and forecast, by type

7.3.7.3.France market size and forecast, by application

7.3.8.UK

7.3.8.1.UK market size and forecast, by technology

7.3.8.2.UK market size and forecast, by type

7.3.8.3.UK market size and forecast, by application

7.3.9.Italy

7.3.9.1.Italy market size and forecast, by technology

7.3.9.2.Italy market size and forecast, by type

7.3.9.3.Italy market size and forecast, by application

7.3.10.Spain

7.3.10.1.Spain market size and forecast, by technology

7.3.10.2.Spain market size and forecast, by type

7.3.10.3.Spain market size and forecast, by application

7.3.11.Rest of Europe

7.3.11.1.Rest of Europe market size and forecast, by technology

7.3.11.2.Rest of Europe market size and forecast, by type

7.3.11.3.Rest of Europe market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities

7.4.2.Market size and forecast, by country

7.4.3.Market size and forecast, by technology

7.4.4.Market size and forecast, by type

7.4.5.Market size and forecast, by application

7.4.6.Japan

7.4.6.1.Japan market size and forecast, by technology

7.4.6.2.Japan market size and forecast, by type

7.4.6.3.Japan market size and forecast, by application

7.4.7.China

7.4.7.1.China market size and forecast, by technology

7.4.7.2.China market size and forecast, by type

7.4.7.3.China market size and forecast, by application

7.4.8.India

7.4.8.1.India market size and forecast, by technology

7.4.8.2.India market size and forecast, by type

7.4.8.3.India market size and forecast, by application

7.4.9.Rest of Asia-Pacific

7.4.9.1.Rest of Asia-Pacific market size and forecast, by technology

7.4.9.2.Rest of Asia-Pacific market size and forecast, by type

7.4.9.3.Rest of Asia-Pacific market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends and opportunities

7.5.2.Market size and forecast, by country

7.5.3.Market size and forecast, by technology

7.5.4.Market size and forecast, by type

7.5.5.Market size and forecast, by application

7.5.6.Brazil

7.5.6.1.Brazil market size and forecast, by technology

7.5.6.2.Brazil market size and forecast, by type

7.5.6.3.Brazil market size and forecast, by application

7.5.7.South Africa

7.5.7.1.South Africa market size and forecast, by technology

7.5.7.2.South Africa market size and forecast, by type

7.5.7.3.South Africa market size and forecast, by application

7.5.8.Rest of LAMEA

7.5.8.1.Rest of LAMEA market size and forecast, by technology

7.5.8.2.Rest of LAMEA market size and forecast, by type

7.5.8.3.Rest of LAMEA market size and forecast, by application

CHAPTER 8:COMPANY PROFILES

8.1.Abbott Laboratories

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Product portfolio

8.1.5.Business performance

8.1.6.Key strategic moves and developments

8.2.Abcam plc.

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Operating business segments

8.2.4.Product Portfolio

8.2.5.Business performance

8.3.Bio-Rad Laboratories, Inc.

8.3.1.Company overview

8.3.2.Company snapshot

8.3.3.Operating business segments

8.3.4.Product portfolio

8.3.5.Business performance

8.3.6.Key strategic moves and developments

8.4.Danaher Corporation

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Operating business segments

8.4.4.Product portfolio

8.4.5.Business performance

8.5.Diasorin S.P.A

8.5.1.Company overview

8.5.2.Company snapshot

8.5.3.Operating business segments

8.5.4.Product portfolio

8.5.5.Business performance

8.5.6.Key strategic moves and developments

8.6.Enzo Biochem, Inc.

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Operating business segments

8.6.4.Product portfolio

8.6.5.Business performance

8.7.F. Hoffmann-La Roche AG (Roche Diagnostics)

8.7.1.Company overview

8.7.2.Company snapshot

8.7.3.Operating business segments

8.7.4.Product portfolio

8.7.5.Business performance

8.7.6.Key strategic moves and developments

8.8.Ortho Clinical Diagnostics

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Operating business segments

8.8.4.Product portfolio

8.8.5.Key strategic moves and developments

8.9.Siemens AG

8.9.1.Company overview

8.9.2.Company snapshot

8.9.3.Operating business segments

8.9.4.Product portfolio

8.9.5.Business performance

8.10.Thermo Fisher Scientific Inc.

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Operating business segments

8.10.4.Product portfolio

8.10.5.Business performance

TABLE 01.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)

TABLE 02.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR RADIOIMMUNOASSAY (RIA), BY REGION, 2019–2027 ($MILLION)

TABLE 03.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR IMMUNOTURBIDITY ASSAYS, BY REGION, 2019–2027 ($MILLION)

TABLE 04.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR IMMUNOPROTEIN ELECTROPHORESIS, BY REGION, 2019–2027 ($MILLION)

TABLE 05.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2019–2027 ($MILLION)

TABLE 06.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)

TABLE 07.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2019 - 2027 ($MILLION)

TABLE 08.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR C-REACTIVE PROTEIN DIAGNOSTIC TESTS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 09.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR COMPLEMENT SYSTEM PROTEIN DIAGNOSTIC TESTS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 10.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR PRE-ALBUMIN DIAGNOSTIC TESTS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 11.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR HAPTOGLOBIN DIAGNOSTIC TESTS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 12.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR IMMUNOGLOBULIN DIAGNOSTIC TESTS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 13.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR FREE LIGHT CHAIN DIAGNOSTIC TESTS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 14.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR OTHERS, BY REGION, 2019 - 2027 ($MILLION)

TABLE 15.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 16.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR AUTOIMMUNE TESTING, BY REGION, 2019–2027 ($MILLION)

TABLE 17.INFECTIOUS DISEASES CAUSED BY BACTERIA, VIRUS AND PARASITES

TABLE 18.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2019–2027 ($MILLION)

TABLE 19.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ALLERGY TESTING, BY REGION, 2019–2027 ($MILLION)

TABLE 20.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ENDOCRINE TESTING, BY REGION, 2019–2027 ($MILLION)

TABLE 21.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ONCOLOGY TESTING, BY REGION, 2019–2027 ($MILLION)

TABLE 22.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR TOXICOLOGY TESTING, BY REGION, 2019–2027 ($MILLION)

TABLE 23.IMMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)

TABLE 24.IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY REGION, 2019-2027 ($MILLION)

TABLE 25.NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2019-2027 ($MILLION)

TABLE 26.NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 27.NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2019-2027 ($MILLION)

TABLE 28.NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2019-2027 ($MILLION)

TABLE 29.U.S. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 30.U.S. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 31.U.S IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 32.CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 33.CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 34.CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 35.MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 36.MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 37.MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 38.EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2019-2027 ($MILLION)

TABLE 39.EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 40.EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2019-2027 ($MILLION)

TABLE 41.EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2019-2027 ($MILLION)

TABLE 42.GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 43.GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 44.GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 45.FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 46.FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 47.FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 48.UK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 49.UK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 50.UK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 51.ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 52.ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 53.ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 54.SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 55.SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 56.SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 57.REST OF EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 58.REST OF EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 59.REST OF EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 60.ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2019-2027 ($MILLION)

TABLE 61.ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 62.ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2019-2027 ($MILLION)

TABLE 63.ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2019-2027 ($MILLION)

TABLE 64.JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 65.JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 66.JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 67.CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 68.CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 69.CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 70.INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 71.INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 72.INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 73.REST OF ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 74.REST OF ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 75.REST OF ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 76.ESTIMATED NUMBER OF NEW CANCER CASES, 2018

TABLE 77.SOUTH AFRICA TOP 10 CAUSES OF DEATH (2017)

TABLE 78.LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2019-2027 ($MILLION)

TABLE 79.LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 80.LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2019-2027 ($MILLION)

TABLE 81.LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2019-2027 ($MILLION)

TABLE 82.BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 83.BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 84.BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 85.SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 86.SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 87.SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 88.REST OF LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TECHNOLOGY, 2019-2027 ($MILLION)

TABLE 89.REST OF LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY TYPE, 2019-2027 ($MILLION)

TABLE 90.REST OF LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET BY APPLICATION, 2019-2027 ($MILLION)

TABLE 91.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 92.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 93.ABBOTT LABORATORIES PLC: PRODUCT PORTFOLIO

TABLE 94.ABCAM: COMPANY SNAPSHOT

TABLE 95.ABCAM: BUSINESS UNITS

TABLE 96.ABCAM: PRODUCT PORTFOLIO

TABLE 97.BIO-RAD: COMPANY SNAPSHOT

TABLE 98.BIO-RAD: PRODUCT SEGMENTS

TABLE 99.BIO-RAD: PRODUCT PORTFOLIO

TABLE 100.DANAHER: COMPANY SNAPSHOT

TABLE 101.DANAHER: OPERATING SEGMENTS

TABLE 102.DANAHER: PRODUCT PORTFOLIO

TABLE 103.DIASORIN: COMPANY SNAPSHOT

TABLE 104.DIASORIN: PRODUCT SEGMENTS

TABLE 105.DIASORIN: PRODUCT PORTFOLIO

TABLE 106.ENZO: COMPANY SNAPSHOT

TABLE 107.ENZO: OPERATING SEGMENTS

TABLE 108.ENZO: PRODUCT PORTFOLIO

TABLE 109.ROCHE: COMPANY SNAPSHOT

TABLE 110.ROCHE: OPERATING BUSINESS SEGMENTS

TABLE 111.ROCHE: PRODUCT PORTFOLIO

TABLE 112.ORTHO: COMPANY SNAPSHOT

TABLE 113.ORTHO: OPERATING BUSINESS SEGMENTS

TABLE 114.ORTHO: PRODUCT PORTFOLIO

TABLE 115.SIEMENS: COMPANY SNAPSHOT

TABLE 116.SIEMENS: OPERATING BUSINESS SEGMENTS

TABLE 117.SIEMENS: PRODUCT PORTFOLIO

TABLE 118.THERMO FISHER: COMPANY SNAPSHOT

TABLE 119.THERMO FISHER: OPERATING SEGMENTS

TABLE 120.THERMO FISHER: PRODUCT PORTFOLIO